Medtronic Expands Spine Surgery Portfolio By Acquiring Medicrea
Medtronic has announced a deal to buy French spinal surgery company Medicrea for about €200m ($228m). The acquisition makes Medtronic the first company to offer an integrated AI-driven spinal surgery solution.
You may also be interested in...
Exec Chat: Medtronic’s Linnea Burman Targets 'Consensus-Driven Care' Using AI, Robotics In Spine Care
Linnea Burman, the general manager of enabling technologies for cranial and spinal technologies at Medtronic, talked to Medtech Insight about plans for the Mazor spinal robotic system, the incoming new president of the division, and other new developments.
Device company Medicrea, which was recently acquired by Medtronic, is paying $2m to resolve allegations the company violated both the False Claims Act and the Open Payments Program.
During Q3 biopharmas reached $41.7bn in merger and acquisition value and drew in $44.4bn in potential deal value from alliances. Device company M&A values reached $17.9bn while in vitro diagnostic firms and research tools players completed M&A activity that totaled $8.2bn.